Deadly Toxin, Potential Medicine — Tetrodotoxin

Tetraodon mbu（Image source：snoopy42，CC0 1.0 ）

Pain is one of the body's fundamental protective mechanisms. When an animal encounters something that causes pain, the unpleasant sensation serves as a warning, prompting it to withdraw and avoid further harm. In most situations, pain triggered by contact with damaging stimuli is a normal physiological response and rarely causes lasting problems. Once the injury heals, the pain typically disappears as well.

However, pain does not always remain within this normal physiological framework. In certain circumstances the nervous system itself begins to malfunction, producing persistent or spontaneous pain signals without any useful purpose. Such abnormal activity can lead to neuropathic or chronic pain, conditions that may persist long after the original cause has disappeared. People suffering from chronic pain often experience prolonged physical distress accompanied by anxiety, emotional changes, and disrupted sleep. For these individuals, analgesic medications become an essential means of reducing suffering and restoring quality of life.

Modern medicine provides a wide variety of pain-relieving drugs. Some act by targeting specific receptors on neurons, while others reduce inflammation that contributes to pain. Among the many possible analgesic compounds, one unusual candidate is tetrodotoxin (TTX), a substance more commonly known for its extreme toxicity.

Tetrodotoxin is best known from pufferfish, but it also occurs in a diverse range of animals, including octopuses, shellfish, frogs, and salamanders. Chemically, it is a highly potent neurotoxin capable of disrupting normal nerve and muscle activity. When tetrodotoxin interferes with the nervous system, the body gradually loses sensory perception and muscular control, and at sufficiently high doses the toxin can cause widespread paralysis and death.

Yet the very property that makes tetrodotoxin dangerous—its ability to interfere with sensory signaling—also suggests a potential medical application. Researchers have long considered the possibility that carefully controlled doses might suppress pathological pain. If administered in precisely regulated amounts, tetrodotoxin could theoretically reduce abnormal nerve activity responsible for chronic pain. Because of its extreme toxicity and the absence of a specific antidote, however, the compound remains tightly restricted in many countries. In the United States it is classified as a controlled substance and is used mainly for research rather than routine clinical treatment.

Tetrodotoxin molecular structure（Image source：US gov，CC0 1.0 ）

The biological target through which tetrodotoxin reduces pain is a group of membrane proteins known as voltage-gated sodium channels. These channels are embedded in the cell membranes of neurons and play a central role in electrical signaling within the nervous system. To understand their importance, it is necessary to examine how nerve cells generate electrical impulses.

In a resting neuron, the outside of the cell membrane carries a positive electrical charge relative to the inside. This electrical difference arises from the unequal distribution of ions across the membrane. Potassium ions (K⁺) are more concentrated inside the cell, while sodium ions (Na⁺) and calcium ions (Ca²⁺) are more abundant outside. Because potassium channels allow potassium ions to move relatively easily, the membrane maintains a stable resting potential of approximately −65 millivolts.

When a neuron receives a chemical signal from another neuron, voltage-gated sodium channels open. Sodium ions then rush into the cell from the extracellular environment, causing the membrane potential to rise rapidly. This process, known as depolarization, reverses the electrical polarity of the membrane and may raise the potential to around +40 millivolts. Shortly afterward, potassium channels open and potassium ions flow out of the cell. The membrane potential then returns toward negative values through repolarization and brief hyperpolarization before settling again at the resting level of about −65 millivolts. This entire sequence constitutes an action potential, the electrical signal that travels along neurons and enables communication throughout the nervous system.

Tetrodotoxin interferes with this process by binding directly to voltage-gated sodium channels and preventing sodium ions from entering the neuron. Without this influx of sodium, the membrane cannot depolarize, action potentials cannot be generated, and electrical signaling is effectively halted. In other words, tetrodotoxin interrupts the transmission of nerve impulses.

Action potential（Image source：Chris 73、Diberri， CC BY-SA 3.0 ）

Action potential propagation（Image source：Germis， CC BY-SA 3.0 ）

Researchers frequently use tetrodotoxin as a molecular tool to study the function of sodium channels. In humans, these channels are composed of two main types of protein subunits: an α-subunit, which forms the core channel responsible for ion conduction, and one or more β-subunits, which assist in regulating channel behavior. Nine major forms of the α-subunit have been identified, designated Nav1.1 through Nav1.9. Each subtype is encoded by a different gene and expressed in different tissues throughout the body. Although sodium channels also appear in some non-neuronal cells, their roles in those contexts remain less well understood.

Interestingly, not all sodium channel subtypes respond to tetrodotoxin in the same way. Nav1.1, Nav1.2, Nav1.3, Nav1.4, Nav1.6, and Nav1.7 are highly sensitive to the toxin and can be blocked by extremely small concentrations in the nanomolar range. In contrast, Nav1.5, Nav1.8, and Nav1.9 are comparatively resistant and require much higher concentrations for inhibition. This difference in sensitivity suggests that carefully controlled doses of tetrodotoxin might selectively affect particular channel types while leaving others relatively unaffected.

Schematic diagram of an ion channel protein（Image source：Crash Course， CC BY 4.0 ）

Most voltage-gated sodium channels play crucial roles in transmitting pain signals from peripheral tissues to the central nervous system, which includes the brain and spinal cord. An exception is Nav1.4, which is primarily expressed in skeletal muscle and therefore does not participate directly in pain perception. In several pathological conditions, certain sodium channels become overexpressed, meaning their abundance increases within neurons. This change can enhance the transmission of electrical signals and intensify the perception of pain.

Among these channels, Nav1.3 has attracted particular attention. Increased expression of Nav1.3 has been observed in damaged nerves and is associated with abnormal nerve excitability. When the number of such channels rises, neurons become more responsive and may fire spontaneously, generating persistent pain signals even in the absence of external stimuli. This mechanism is thought to contribute significantly to neuropathic pain.

Pain perception itself begins with specialized nerve fibers located in tissues such as the skin. Two major classes of fibers—Aδ fibers and C fibers—carry signals related to painful stimuli. The cell bodies of these neurons reside in clusters called dorsal root ganglia near the spinal cord. When tissue damage or mechanical pressure activates these fibers, electrical signals travel along their axons to the spinal cord and then onward to the brain, where the somatosensory cortex interprets them as pain.

If sodium channel expression increases within these neurons, electrical signals propagate more easily and more frequently. As a result, even minor stimuli may trigger exaggerated responses, a condition known as hyperalgesia, in which pain sensitivity becomes abnormally heightened.

Pain transmission pathway（Image source：Nikolenko et al， CC BY-NC 3.0 ）

Because tetrodotoxin blocks sodium channels, it can interrupt this pathological signaling. By binding to amino acid residues located around the channel pore, the toxin prevents sodium ions from entering the neuron. Without sodium influx, action potentials cannot be initiated, and the electrical signals responsible for pain fail to propagate. In effect, tetrodotoxin can shut down the abnormal nerve activity that underlies certain forms of chronic pain.

Clinical studies have explored this possibility in patients suffering from severe cancer-related pain. In one trial, participants received subcutaneous injections of tetrodotoxin at daily doses ranging from 15 to 90 micrograms for four consecutive days. The treatment significantly reduced pain in many patients, and the relief often lasted for up to two weeks after the injections ended. These results suggest that tetrodotoxin, despite its toxicity, may possess genuine therapeutic potential when administered under carefully controlled conditions.

The story of tetrodotoxin illustrates a broader principle in pharmacology. Many substances that are dangerous or even lethal can become valuable medicines when their properties are thoroughly understood and their dosage precisely controlled. With careful research and responsible application, a compound once feared solely as a deadly poison may ultimately find a place in medicine as a tool for relieving human suffering.

Author: Shui-Ye You

Reference:

Nieto, F. R. et al. (2012). Tetrodotoxin (TTX) as a therapeutic agent for pain. Mar Drugs.

（Paid content. Unauthorized reproduction or use is prohibited.）